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\s=b\This controlled double-blind study
examined the efficacy of a single large
inoculum of Staphylococcus aureus 502A
in interrupting intrafamilial spread of
recurrent staphylococcal abscesses. For-
ty families were enrolled in the study and
32 completed six months of follow-up
care. All participants were first treated
with oral oxacillin sodium or dicloxacillin
sodium, twice daily hexachlorophene
showers, and bacitracin given nasally for
two weeks. Some then received nasal
inoculation of 108 to 10 organisms of S
aureus 502A while others were given only
sterile broth. Fifteen of 17 families or 29 of
36 individuals who received 502A re-
mained free of recurrence for six months
of observation, while only four of 15
control families or 18 of 34 members had
no recurrences (P < .005). After six
months after colonization, 83% of the
treatment group retained the 502A organ-
ism.
(Arch Dermatol 116:189-190, 1980)
Intact skin and mucous membraneswith their normal bacterial micro-
flora constitute the host's primary
defense against invasion by microbial
agents. Any alteration of this basic
barrier may result in covert or overt
infectious processes. Furuncles and
subcutaneous abscesses probably rep¬
resent the most commonly encoun¬
tered forms of infection and account
for as many as one in every 50 visits to
hospital emergency facilities.' More¬
over, skin infections tend to be recur¬
rent in many patients and often
spread to other family members.
Medical intervention is most appro¬
priately directed toward eradication
of the offending organism and, for
recurrent infections, toward strength¬
ening the patient's resistance to infec¬
tion.
Previous studies have demonstrated
that artificial colonization with the
502A strain of Staphylococcus aureus
interferes with subsequent coloniza¬
tion by more virulent strains of S
aureus in neonates- and adults.'"
Protection against recurrent intra-
familial furunculosis by repeated inoc¬
ulation of Staphylococcus 502A has
also been reported.7 This controlled
study was designed to examine the
efficacy of a single large inoculum of
502A in curtailing staphylococcal in¬
fection in families having a history of
recurrent furunculosis.
MATERIALS AND METHODS
Clinical Data
Criteria for inclusion in the study
included the following: (1) five or more
deep furuncles among family members in
the previous three months, (2) nasal
carriage of S aureus in more than one
family member, and (3) negative history
for penicillin allergy in all family mem¬
bers.
Forty qualified families were randomly
allotted into a 502A or control nasal inocu¬
lation group after the nature of the proce¬
dures was explained and informed consent
was obtained. Nasal cultures were first
obtained in all participants who were then
treated with oral oxacillin sodium suspen¬
sion (50 mg/kg/24 hr, with a maximum of 1
g for children) or dicloxacillin sodium
tablets (2 g daily for adults), twice daily
hexachlorophene showers, and twice daily
bacitracin given nasally for 14 days.
Furuncles present were incised and
drained. Nasal cultures were obtained two
days after this course of therapy and again
two weeks and six months after nasal
application of 502A or control material.
Nasal inoculation was carried out two days
after the completion of antibiotic, shower,
and nasal bacitracin therapy.
During the six-month observation peri¬
od, any study subject manifesting a
staphylococcal skin infection that was larg¬
er than 10 mm or caused pain was consid¬
ered a treatment failure. The entire family
then repeated the sequence of antibiotics
administered for systemic and local effect
and hexachlorophene showers for 14 days
followed by nasal inoculation of S aureus
502A.
Bactériologie Data
Nasal cultures were obtained from all
participating subjects with a sterile cotton
swab that was incubated at 37 °C in tryp-
ticase soy broth (TSB) for two hours prior
to streaking on sheep blood agar plates.
After 24 to 48 hours' incubation, represen¬
tative coagulase-positive colonies were
selected for antibiotic sensitivity testing
and phage typing. Abscesses and other
systemic foci of infection were cultured in
a similar manner before and during the
observation period.
The S aureus 502A strain used in this
study has been previously characterized.' A
stock slant was originally streaked on tryp-
ticase soy agar plates and multiple colonies
were inoculated into a suspension of sheep
RBC. One-milliliter aliquot parts were then
frozen at -20 °C until used; control sheep
cells were maintained in a similar fashion.
Twenty-four to 36 hours prior to nasal
treatment, a culture tube was thawed, an
equal volume of TSB was added, and the
broth culture was incubated at 37 °C. Colo¬
ny counts of 502A material yielded 10" to
10" organisms per milliliter.
The sheep cell-TSB broth was inoculated
into the anterior nares using a sterile
cotton swab with the subject "sniffing" the
material back to the posterior part of the
nasopharynx. This method of colonization
was employed only once during the study
unless recurrent infection indicated treat¬
ment failure.
RESULTS
Thirty-two families, 17 treated and
15 control families including 70 indi¬
viduals, 36 treated and 34 control
subjects, completed six months of
follow-up care. A systemic staphylo¬
coccal illness preceded entry into the
study for two families; one family
member had septic arthritis and
another had staphylococcal pneumo¬
nia. Only two isolated strains in the 32
families were sensitive to penicillin
and no predominant phage group was
identified in this series. In the treat¬
ment group, 22 of 36 (61%) family
members originally carried the of¬
fending staphylococcal strain, while
25 of 34 (74%) of the control group
demonstrated nasal colonization. All
cultures were negative for S aureus
prior to nasal inoculation of 502A or
control broth. Nasal colonization data
during the course of this study are
presented in Table 1.
Clinical efficacy data are presented
in Table 2. It can be seen that nasal
inoculation of 502A significantly pre¬
vented subsequent episodes of staphy¬
lococcal infection. Of the seven pa¬
tients who were treatment failures in
the group inoculated with 502A, none
had 502A in their anterior nares at the
time of recurrence. Nasal cultures in
the control group revealed the same
phage type of S aureus as that recov¬
ered from the furuncle in nine of 16
treatment failures. The procedure was
tolerated well by all participants and
no untoward side effects were ob¬
served in this study.
COMMENT
This study demonstrates the effica¬
cy of a single nasal inoculum of S
aureus 502A for interrupting bacteri¬
al colonization with more virulent
organisms and for preventing subse¬
quent overt infection. This confirms
other reports that use similar ap¬
proaches referred to as "artificial
colonization"2 or "bacterial interfer-
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Table 1.—Staphylococcal Nasal Colonization During Study Period
Time Culture Obtained
502A-Colonized Group, No. (%)- Control Group, No. (%)
Non-502A
Staphylococcus
502A
Staphylococcus
Non-502A
Staphylococcus
502A
Staphylococcus
Initially 22/36(61)* 25/34(74)
Prior to nasal inoculation 0/36 (0) 0/34 (0)
2 wk after inoculation 0/36 (0) 34/36(94) 4/31 (13)
6 mo after inoculation 2/29 (7) 24/29 (83) 4/18(22)
'Treatment failures not included in these data.
Table 2.—Clinical Efficacy of Staphylococcus 502A Colonization
Families* Individuals
Total No.
Treatment
Failures, No. Total No.
Treatment
Failures, No.
502A-Colonized
Control
17
15
36
34 16
~P < .005
IP < .05
ence."3"s Essentially, the mechanism
is, in part, restoration of the host's
primary immune barrier against in¬
fection, ie, noninvasive bacterial mi¬
croflora. Certainly colonization with
virulent S aureus strains on other skin
surfaces (perineum, axilla) or mucous
membrane areas could account for
treatment failures. However, this
study demonstrates the importance of
nasal colonization as a focus for subse¬
quent dissemination of bacteria.
The methods in this protocol differ
from previous ones in that the 502A
broth was given as a single inoculum
following long-term freezer storage of
the bacterium. Thus, practical applica¬
tion was achieved for use of this tech¬
nique in most outpatient facilities.
The only equipment requirements are
a standard freezer compartment and a
small 37 °C incubator. Aliquot parts of
inoculated sheep cells may be readily
prepared in a microbiologie laboratory
and sent to clinical facilities for stor¬
age and subsequent use.
The initial treatment of cutaneous
abscesses often involves incision and
drainage with the necessity for anti¬
biotics given for systemic effect
remaining debatable; the aerobe most
prevalent in recovery from cutaneous
abscesses is S aureus. A recent report
demonstrated that there is no appar¬
ent therapeutic benefit following rou¬
tine Gram's stains or cultures of such
infections and antimicrobial therapy.'
However, no study to date has
adequately evaluated recurrence or
extension of abscesses with and with¬
out antibiotic therapy following initial
Gram's stain and culture identifica¬
tion of organisms. In practice, the
disease process is usually considered
too trivial for an expensive laboratory
evaluation and treatment approach.
Differences in virulence of S aureus
strains account for occasionally
greater potential for more serious
infection. This study did not suggest
that these phage types were more
resistant to colonization with 502A as
a therapeutic approach.
Systemic spread of S aureus from a
subcutaneous focus is rare in the
nonimmunologically compromised
host. However, experience with two
individuals in the current series sug¬
gests that colonization with virulent
Staphylococcus sp is related to sys¬
temic disease. One study patient had
septic arthritis and another had pneu¬
monia with the strain phage types
that were also recovered from the
nasal flora and, in the former case,
from a concomitant cutaneous ab¬
scess. It is the appreciation of such
systemic spread that supports initial
treatment with antibiotics, and this
therapy is still a common practice
among physicians.
Skin and mucous membrane infec¬
tions caused by S aureus 502A follow¬
ing therapeutic colonization have been
reported.1 s" These lesions, however,
have not been of serious consequence.
Potentially greater risk might be
anticipated in the host with compro¬
mised immunologie responses. There¬
fore, in patients who have histories
compatible with abnormal host de¬
fenses, particularly granulocyte pha¬
gocytic responses, a more thorough
immunologie evaluation should be pro¬
vided. We have treated one patient
with hypergammaglobulinemia E and
cyclic chemotactic dysfunction by
502A colonization and considerable
therapeutic benefit has been obtained.
Therapeutic colonization with selected
benign microflora is currently being
employed for patients who have
undergone bone marrow transplanta¬
tion,'" and this approach to treatment
has also been suggested in a number
of other clinical circumstances.'""
This project was initiated by the Department
of Pediatrics, University of Arkansas for Medical
Sciences, Little Rock, to acknowledge active
participation in the International Year of the
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The S aureus strain used in this study was
supplied by Henry R. Shinefield, MD.
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